Announcement
On August 18, 2026, Fractal Analytics Ltd (BSE: 544700, NSE: FRACTAL), a globally recognized pure‑play enterprise AI company, issued a press release from Mumbai stating that it has secured a multi‑year agreement valued at more than US$17 million with a leading U.S. healthcare organization. The contract aims to modernize the client’s Data and AI foundation on the Databricks platform and to support the client’s journey toward becoming an AI‑ready enterprise.
Deal Scope and Services
The engagement includes 24‑by‑7 managed data operations, consolidating support from multiple vendors under Fractal as the single strategic partner. Fractal will integrate Agentic Ops to create a scalable, governed, and resilient platform designed to accelerate AI adoption, reduce technical debt, optimise total cost of ownership and enable continuous innovation.
Fractal’s AI Foundations Pillar
Fractal highlighted its AI Foundations (AIF) pillar, which focuses on building AI‑ready enterprises through modern data foundations, enterprise knowledge layers, AI governance and managed operations. The pillar will deliver a scalable, governed AI platform that supports enterprise‑scale deployment of AI solutions.
Healthcare & Life Sciences Practice
Fractal’s Healthcare & Life Sciences (HLS) practice partners with healthcare payers, providers, pharmaceutical and medical‑technology organisations, delivering solutions across clinical and care management, population health, value‑based care, underwriting and risk management, claims and payment integrity, marketing content generation, dynamic targeting, forecasting, patient service programmes, field operations, medical affairs, clinical‑trial acceleration and other areas.
Executive Comments
Matt Gennone, Chief Commercial Officer of Fractal and CEO of Cogentiq, said the deal reflects the new era where AI can help healthcare organisations make faster, smarter decisions across the care journey and that Fractal is focused on delivering practical healthcare AI that drives measurable impact. Srikanth Velamakanni, Co‑founder, Group Chief Executive and Vice‑Chairman of Fractal, noted that enterprises are moving from isolated pilots to enterprise‑scale AI deployment, requiring strong AI foundations, and that Fractal’s deep domain expertise, proprietary IP and outcome‑based delivery uniquely position it to support this transformation.
Company Profile and Investment
Fractal employs more than 6,000 professionals across North America, EMEA and Asia‑Pacific. It invests over 6% of its revenue in AI research and development, supporting foundational AI research, product development and IP creation. The company’s flagship agentic AI platform, Cogentiq, powers its three strategic pillars: AI‑led Transformation (AIT), AI Foundations (AIF) and AI Work & Workforce (AIW). Fractal’s portfolio includes proprietary models and products such as Vaidya.ai and PiEvolve, the spin‑out Qure.ai (a global healthcare AI leader), the revenue‑growth‑management product Asper.ai for CPG companies, and the ed‑tech platform Analytics Vidhya.
Disclaimer
The release states that it is for general informational purposes only, does not constitute an offer to purchase securities, contains forward‑looking statements subject to risks and uncertainties, and that the company does not undertake any obligation to update such statements. The information has not been independently verified and investors are advised to seek independent professional advice.